Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Oversight Of DTC Ads Will Be Examined By HHS Inspector General

This article was originally published in The Pink Sheet Daily

Executive Summary

The Inspector General will determine the effectiveness of FDA procedures for monitoring DTC ads and what actions are taken against companies with false and misleading ads, the IG’s fiscal 2005 work plan says. FDA’s handling of off-label drug promotions will also be studied.

You may also be interested in...



New Labeling Rule Will Require Rx Warnings To Appear At Beginning Of DTC Ads

The proposed physician labeling rule will by published by the end of November, FDA Acting Commissioner Crawford says. The rule is designed to provide more useful information to physicians and patients.

New Labeling Rule Will Require Rx Warnings To Appear At Beginning Of DTC Ads

The proposed physician labeling rule will by published by the end of November, FDA Acting Commissioner Crawford says. The rule is designed to provide more useful information to physicians and patients.

Medicare, Medicaid Rx Price Reporting Are IG Review Priorities For 2005

The HHS Inspector General will conduct several reviews related to drug manufacturers' price reporting for Medicare and Medicaid, IG's fiscal 2005 work plan says

Related Content

Topics

UsernamePublicRestriction

Register

PS057812

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel